Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats

Kambiz Kalantarinia, Alaa S Awad, Helmy M. Siragy

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Background. The development of diabetic nephropathy has been linked to the release of vasoactive hormones and growth factors. Currently the role of inflammatory cytokines in this pathogenic process is not clear. Methods. We utilized the microdialysis technique to monitor early changes in tumor necrosis-α (TNF-α) levels in the renal interstitial fluid and urine of conscious Sprague-Dawley rats (N = 8) before and after induction of diabetes with streptozotocin (STZ). Measurement of the urinary albumin excretion (UAE) was utilized to monitor the development and progression of diabetic nephropathy. Results. UAE increased from 0.56 ± 0.20 μg/min to 8.14 ± 2.98 μg/min 17 days after induction of diabetes (P = 0.01). Renal interstitial fluid TNF-α increased from 11.96 ± 5.32 pg/mL at baseline to 45.02 ± 11.69 pg/mL 5 days after induction of diabetes (P = 0.03). Renal interstitial fluid TNF-α levels remained elevated throughout the remainder of the study period. Urinary TNF-α also increased significantly compared to baseline 3 days after induction of diabetes (294.18 ± 36.94 pg/mL vs. 16.05 ± 6.07 pg/mL, P < 0.002). There was a second significant rise in urinary TNF-α concentration to 638.16 ± 36.94 pg/mL 21 days after induction of diabetes (P < 0.001). Serum TNF-α levels were undetectable before STZ injection and remained undetectable by the end of the study. Urinary and renal interstitial fluid TNF-α in the control rats (N = 5) did not change throughout the study. Conclusion. We found an early rise in renal TNF-α levels after induction of diabetes with STZ, which precedes the rise in UAE by about 2 weeks. These findings suggest a possible contribution of TNF-α in the complicated pathogenic process resulting in microalbuminuria in diabetes.

Original languageEnglish (US)
Pages (from-to)1208-1213
Number of pages6
JournalKidney International
Volume64
Issue number4
DOIs
StatePublished - Oct 1 2003
Externally publishedYes

Fingerprint

Albuminuria
Extracellular Fluid
Kidney
Albumins
Experimental Diabetes Mellitus
Diabetic Nephropathies
Microdialysis
Streptozocin
Sprague Dawley Rats
Intercellular Signaling Peptides and Proteins
Necrosis
Urine
Hormones
Cytokines
Injections
Serum
Neoplasms

Keywords

  • Albuminaria
  • Diabetes
  • Diabetic nephropathy
  • Microdialysis
  • Renal interstitium
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Nephrology

Cite this

Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats. / Kalantarinia, Kambiz; Awad, Alaa S; Siragy, Helmy M.

In: Kidney International, Vol. 64, No. 4, 01.10.2003, p. 1208-1213.

Research output: Contribution to journalArticle

@article{701d5f1ab43341b8bf34c60ccea8ae9a,
title = "Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats",
abstract = "Background. The development of diabetic nephropathy has been linked to the release of vasoactive hormones and growth factors. Currently the role of inflammatory cytokines in this pathogenic process is not clear. Methods. We utilized the microdialysis technique to monitor early changes in tumor necrosis-α (TNF-α) levels in the renal interstitial fluid and urine of conscious Sprague-Dawley rats (N = 8) before and after induction of diabetes with streptozotocin (STZ). Measurement of the urinary albumin excretion (UAE) was utilized to monitor the development and progression of diabetic nephropathy. Results. UAE increased from 0.56 ± 0.20 μg/min to 8.14 ± 2.98 μg/min 17 days after induction of diabetes (P = 0.01). Renal interstitial fluid TNF-α increased from 11.96 ± 5.32 pg/mL at baseline to 45.02 ± 11.69 pg/mL 5 days after induction of diabetes (P = 0.03). Renal interstitial fluid TNF-α levels remained elevated throughout the remainder of the study period. Urinary TNF-α also increased significantly compared to baseline 3 days after induction of diabetes (294.18 ± 36.94 pg/mL vs. 16.05 ± 6.07 pg/mL, P < 0.002). There was a second significant rise in urinary TNF-α concentration to 638.16 ± 36.94 pg/mL 21 days after induction of diabetes (P < 0.001). Serum TNF-α levels were undetectable before STZ injection and remained undetectable by the end of the study. Urinary and renal interstitial fluid TNF-α in the control rats (N = 5) did not change throughout the study. Conclusion. We found an early rise in renal TNF-α levels after induction of diabetes with STZ, which precedes the rise in UAE by about 2 weeks. These findings suggest a possible contribution of TNF-α in the complicated pathogenic process resulting in microalbuminuria in diabetes.",
keywords = "Albuminaria, Diabetes, Diabetic nephropathy, Microdialysis, Renal interstitium, Tumor necrosis factor",
author = "Kambiz Kalantarinia and Awad, {Alaa S} and Siragy, {Helmy M.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1046/j.1523-1755.2003.00237.x",
language = "English (US)",
volume = "64",
pages = "1208--1213",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats

AU - Kalantarinia, Kambiz

AU - Awad, Alaa S

AU - Siragy, Helmy M.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Background. The development of diabetic nephropathy has been linked to the release of vasoactive hormones and growth factors. Currently the role of inflammatory cytokines in this pathogenic process is not clear. Methods. We utilized the microdialysis technique to monitor early changes in tumor necrosis-α (TNF-α) levels in the renal interstitial fluid and urine of conscious Sprague-Dawley rats (N = 8) before and after induction of diabetes with streptozotocin (STZ). Measurement of the urinary albumin excretion (UAE) was utilized to monitor the development and progression of diabetic nephropathy. Results. UAE increased from 0.56 ± 0.20 μg/min to 8.14 ± 2.98 μg/min 17 days after induction of diabetes (P = 0.01). Renal interstitial fluid TNF-α increased from 11.96 ± 5.32 pg/mL at baseline to 45.02 ± 11.69 pg/mL 5 days after induction of diabetes (P = 0.03). Renal interstitial fluid TNF-α levels remained elevated throughout the remainder of the study period. Urinary TNF-α also increased significantly compared to baseline 3 days after induction of diabetes (294.18 ± 36.94 pg/mL vs. 16.05 ± 6.07 pg/mL, P < 0.002). There was a second significant rise in urinary TNF-α concentration to 638.16 ± 36.94 pg/mL 21 days after induction of diabetes (P < 0.001). Serum TNF-α levels were undetectable before STZ injection and remained undetectable by the end of the study. Urinary and renal interstitial fluid TNF-α in the control rats (N = 5) did not change throughout the study. Conclusion. We found an early rise in renal TNF-α levels after induction of diabetes with STZ, which precedes the rise in UAE by about 2 weeks. These findings suggest a possible contribution of TNF-α in the complicated pathogenic process resulting in microalbuminuria in diabetes.

AB - Background. The development of diabetic nephropathy has been linked to the release of vasoactive hormones and growth factors. Currently the role of inflammatory cytokines in this pathogenic process is not clear. Methods. We utilized the microdialysis technique to monitor early changes in tumor necrosis-α (TNF-α) levels in the renal interstitial fluid and urine of conscious Sprague-Dawley rats (N = 8) before and after induction of diabetes with streptozotocin (STZ). Measurement of the urinary albumin excretion (UAE) was utilized to monitor the development and progression of diabetic nephropathy. Results. UAE increased from 0.56 ± 0.20 μg/min to 8.14 ± 2.98 μg/min 17 days after induction of diabetes (P = 0.01). Renal interstitial fluid TNF-α increased from 11.96 ± 5.32 pg/mL at baseline to 45.02 ± 11.69 pg/mL 5 days after induction of diabetes (P = 0.03). Renal interstitial fluid TNF-α levels remained elevated throughout the remainder of the study period. Urinary TNF-α also increased significantly compared to baseline 3 days after induction of diabetes (294.18 ± 36.94 pg/mL vs. 16.05 ± 6.07 pg/mL, P < 0.002). There was a second significant rise in urinary TNF-α concentration to 638.16 ± 36.94 pg/mL 21 days after induction of diabetes (P < 0.001). Serum TNF-α levels were undetectable before STZ injection and remained undetectable by the end of the study. Urinary and renal interstitial fluid TNF-α in the control rats (N = 5) did not change throughout the study. Conclusion. We found an early rise in renal TNF-α levels after induction of diabetes with STZ, which precedes the rise in UAE by about 2 weeks. These findings suggest a possible contribution of TNF-α in the complicated pathogenic process resulting in microalbuminuria in diabetes.

KW - Albuminaria

KW - Diabetes

KW - Diabetic nephropathy

KW - Microdialysis

KW - Renal interstitium

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0141674965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141674965&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2003.00237.x

DO - 10.1046/j.1523-1755.2003.00237.x

M3 - Article

VL - 64

SP - 1208

EP - 1213

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 4

ER -